USPTO serial 87200486
CULLINAN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- CLYBURN, CARLA DIONNE
- Law office
- TMO LAW OFFICE 110 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with CULLINAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gwenn Roos
GWENN ROOS LAW OFFICE OF GWENN ROOS26 BROOKDALE AVENUEWELLESLEY, MA 02482UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of technology in the field of oncology; Research and development of vaccines and medicines; Research in the field of oncology; Research in the field of oncology; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Conducting clinical trials for others; Conducting clinical trials for others in the field of oncology; Conducting scientific research in the field of oncology at animal sanctuary facilities; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Genetic testing for scientific research purposes; Laboratory research in the field of oncology; Laboratory research services relating to pharmaceuticals; Medical research; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of oncology; Medical and scientific research information in the field of oncology; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Pharmaceutical research and development; Pharmaceutical research services; Product research and development; Providing a website featuring educational information in the field of clinical research; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical research and scientific research information in the field of oncology via the Internet; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical research and scientific research information in the field of oncology via the Internet; Providing medical testing services and information in the field of cancer research and disease classification; Providing medical testing services and information in the field of cancer research and disease classification; Providing scientific research information in the field of oncology; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research; Scientific research and development; Scientific research consulting in the field of oncology; Scientific research for medical purposes in the field of oncology; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of oncology; Scientific study and research in the field(s) of oncology; Technical research in the field of pharmaceutical studies; Technology consultation and research in the field of oncology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 1, 2018 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jun 13, 2018 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 13, 2018 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 3, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 3, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 3, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 12, 2017 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Sep 19, 2017 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Aug 31, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 31, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 31, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 31, 2017 | ALIE | ASSIGNED TO LIE | — |
| Aug 16, 2017 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Aug 15, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 15, 2017 | PETG | PETITION TO REVIVE-GRANTED | — |
| Aug 15, 2017 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jan 18, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 17, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 17, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 15, 2016 | NWAP | NEW APPLICATION ENTERED | — |